Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease

Journal of Neuroscience

Volumn 33, Issue 9, 2013, Pages 4206-4210

  Mealer, Robert G ^a   Subramaniam, Srinivasa ^a   Snyder, Solomon H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; RAS HOMOLOG ENRICHED IN STRIATUM PROTEIN; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; FALLING; GENE DELETION; HUNTINGTON CHOREA; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROTOXICITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; TASK PERFORMANCE; TRAINING;

ANIMALS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GTP-BINDING PROTEINS; HUNTINGTON DISEASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROTOXINS; NITRO COMPOUNDS; PROPIONATES; PSYCHOMOTOR PERFORMANCE; SUCCINATE DEHYDROGENASE;

EID: 84874610368     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3730-12.2013     Document Type: Article

References (27)

1. Banerjee R, Beal MF, Thomas B (2010) Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci 33:541-549. CrossRef Medline
2. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181-4192. Medline
3. Blum D, Galas MC, Pintor A, Brouillet E, Ledent C, Muller CE, Bantubungi K, Galluzzo M, Gall D, Cuvelier L, Rolland AS, Popoli P, Schiffmann SN (2003) A dual role of adenosine A2A receptors in 3-nitropropionic acidinduced striatal lesions: implications for the neuroprotective potential of A2A antagonists. J Neurosci 23:5361-5369. Medline
4. Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794-805. Medline
5. Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 95: 1521-1540. CrossRef Medline
6. Crook ZR, Housman D (2011) Huntington's disease: can mice lead the way to treatment? Neuron 69:423-435. CrossRef Medline
7. Ehrnhoefer DE, Sutton L, Hayden MR (2011) Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist 17:475-492. CrossRef Medline
8. Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A (2008) The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Mol Cell Neurosci 37:333-345. CrossRef Medline
9. Falk JD, Vargiu P, Foye PE, Usui H, Perez J, Danielson PE, Lerner DL, Bernal J, Sutcliffe JG (1999) Rhes: A striatal-specific Ras homolog related to Dexras1. J Neurosci Res 57:782-788. CrossRef Medline
10. Harris H, Rubinsztein DC (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 8:108-117. CrossRef Medline
11. Jimenez-Sanchez M, Thomson F, Zavodszky E, Rubinsztein DC (2012) Autophagy and polyglutamine diseases. Prog Neurobiol 97:67-82. CrossRef Medline
12. Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, Artates JW, Weiss A, Cheng SH, Shihabuddin LS, Hung G, Bennett CF, Cleveland DW (2012) Sustained therapeutic reversal of Huntington's disease by transient repression of Huntingtin synthesis. Neuron 74:1031-1044. CrossRef Medline
13. Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, Kaushik S, de Vries R, Arias E, Harris S, Sulzer D, Cuervo AM (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat Neurosci 13:567-576. CrossRef Medline
14. Mealer RG, Snyder SH (2012) Rhes is a striatal-enriched protein with pathophysiologic relevance. Eur J Neurodegen Dis 1:89-100.
15. Quintero GC, Spano D (2011) Exploration of sex differences in Rhes effects in dopamine mediated behaviors. Neuropsychiatr Dis Treat 7:697-706. CrossRef Medline
16. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36:585-595. CrossRef Medline
17. Ross CA, Tabrizi SJ (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83-98. CrossRef Medline
18. Sah DW, Aronin N (2011) Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest 121:500-507. CrossRef Medline
19. Seredenina T, Gokce O, Luthi-Carter R (2011) Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. PLoS One 6:e22231. CrossRef Medline
20. Spano D, Branchi I, Rosica A, Pirro MT, Riccio A, Mithbaokar P, Affuso A, Arra C, Campolongo P, Terracciano D, Macchia V, Bernal J, Alleva E, Di Lauro R (2004) Rhes is involved in striatal function. Mol Cell Biol 24: 5788-5796. CrossRef Medline
21. Steffan JS (2010) Does Huntingtin play a role in selective macroautophagy? Cell Cycle 9:3401-3413. CrossRef Medline
22. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, Illes K, Lukacsovich T, Zhu YZ, Cattaneo E, Pandolfi PP, Thompson LM, Marsh JL (2004) SUMO modification of Huntingtin and Huntington's disease pathology. Science 304:100-104. CrossRef Medline
23. Subramaniam S, Sixt KM, Barrow R, Snyder SH (2009) Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324:1327-1330. CrossRef Medline
24. Subramaniam S, Napolitano F, Mealer RG, Kim S, Errico F, Barrow R, Shahani N, Tyagi R, Snyder SH, Usiello A (2011) Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Nat Neurosci 15:191-193. CrossRef Medline
25. Tsvetkov AS, Miller J, Arrasate M, Wong JS, Pleiss MA, Finkbeiner S (2010) A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc Natl Acad Sci U S A 107:16982-16987. CrossRef Medline
26. Vargiu P, De Abajo R, Garcia-Ranea JA, Valencia A, Santisteban P, Crespo P, Bernal J (2004) The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 23: 559-568. CrossRef Medline
27. Zheng S, Clabough EB, Sarkar S, Futter M, Rubinsztein DC, Zeitlin SO (2010) Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet 6:e1000838. CrossRef Medline